Here n = 69 patients with squamous cell carcinoma (51%) expressed PSMA in tumor-associated neovasculature, whereas n = 88 patients with non-squamous cell carcinoma (63%) were negative for neovascular PSMA expression (p = 0.021, two-sided Fisher’s exact test). The gene discussed is FOLH1; the disease is squamous cell carcinoma.